37
Participants
Start Date
February 3, 2020
Primary Completion Date
February 28, 2027
Study Completion Date
February 28, 2041
C7R-GD2.CART cells (IV and ICV infusion)
"Dose levels administered are by IV infusion followed by ICV infusion.~Cycle 1: 10 million cells/m2 delivered IV with lymphodepletion.~Cycle 2 (and subsequent cycles):~Dose level 1: 2 million cells ICV with lymphodepletion. Dose level 2: 5 million cells ICV with lymphodepletion."
C7R-GD2.CAR T cells (IV infusion)
Dose levels administered are by IV infusion. For all cycles, the dose level is 10 million cells/m2 IV with lymphodepletion.
RECRUITING
Texas Children's Hospital, Houston
Center for Cell and Gene Therapy, Baylor College of Medicine
OTHER
The Faris Foundation
UNKNOWN
ChadTough Defeat DIPG Foundation
UNKNOWN
Violet Foundation for Pediatric Brain Cancer
UNKNOWN
Baylor College of Medicine
OTHER